EZH2 and central nervous system cancer: The other study received findings that showed exosomes from MSC carrying miR-133b decreased glioma size through the Wnt/β-catenin pathway by silencing Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2).